eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2011
vol. 62
 
Share:
Share:
abstract:

Vanadium compounds affect growth and morphology of human rhabdomyosarcoma cell line

Wojciech Dąbroś
,
Anna Adamczyk
,
Katarzyna Ciurkot
,
Anna M. Kordowiak

POL J PATHOL 2011; 4: 262-268
Online publish date: 2012/01/10
View full text Get citation
 
Rhabdomyosarcoma (RMS) cells were incubated with four vanadium compounds: cations BMOV and vanadyl sulphate, and anions ortho- and metavanadate. Growth inhibition of RMS cells in the culture was determined by two staining methods: with N-hexamethylpararosaniline (crystal violet = CV) or bromide 3-(4,5-dimethylthiazol-2)-2,5-diphenyltetrazolium (MTT). After 48 h incubation with 10-40 μM for NaVO3 or 20-40 μM for the other three vanadium salts, the results were statistically significantly lower (0.001 < p < 0.01) as compared to the controls (without vanadium in the medium). A vanadium concentration higher than 40 μM resulted in cell destruction or death in all cells. A comparison with our previously obtained results showed the greatest sensitivity of rat hepatoma H 35-19 cells in comparison to four human cancer cell lines (A549, DU145, HTB, RMS). Investigations of human cancer cells demonstrated that the highest resistance to orthovanadate was characteristic of RMS (c.40 μM) and HTB (c. 20 μM). Electron microscopic examination showed pleomorphic nuclei with visible amounts of heterochromatin and large nucleoli, characteristic of RMS cells. Cells at various stages of differentiation were observed.
keywords:

human cancer cells, autocrine growth and morphology of RMS cells, vanadyl sulphate (VOSO4), BMOV = bis(maltolato)oxovanadium, sodium orthovanadate (Na3VO4), sodium metavanadate (NaVO3)

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.